Publication Cover
Hemoglobin
international journal for hemoglobin research
Volume 44, 2020 - Issue 6
89
Views
0
CrossRef citations to date
0
Altmetric
Short Communications

Twelve Cases of Hb Manitoba [α102(G9)Ser→Arg]: the Fluctuation in the Variant Expression

ORCID Icon, , , &
Pages 442-445 | Received 22 Oct 2020, Accepted 05 Nov 2020, Published online: 29 Nov 2020

References

  • Molchanova TP, Pobedimskaya DD, Huisman THJ. The differences in quantities of alpha 2- and alpha 1-globin gene variants in heterozygotes. Br J Haematol. 1994;88(2):300–306.
  • Chang JG, Shih MC, Liu SC, et al. Hb Manitoba in a Taiwanese family: a C→A substitution at codon 102 of the α2-globin gene. Hemoglobin. 2001;25(4):437–439.
  • Henderson SJ, Timbs AT, McCarthy J, et al. Ten years of routine α- and β-globin gene sequencing in UK hemoglobinopathy referrals reveals 60 novel mutations. Hemoglobin. 2016;40(2):75–84.
  • Crookston JH, Farquharson HA, Kinderlerer JL, et al. Hemoglobin Manitoba: alpha 102(G9) serine replaced by arginine. Can J Biochem. 1970;48(8):911–914.
  • Wrightstone RN, Smith LL, Wilson JB, et al. Some physicochemical properties of hemoglobin-manitoba (alpha2 102Ser replaced by Arg (G9) beta2). Biochim Biophys Acta. 1975;412(2):283–287.
  • Wong SC, Tesanovic M, Poon MC. Detection of two abnormal hemoglobins, Hb Manitoba and Hb G-Coushatta, during analysis of glycohemoglobin (A1c) by high-performance liquid chromatography. Clin Chem. 1991;37(8):1456–1459.
  • Sciarratta GV, Ivaldi G, Molaro GL, et al. The characterization of Hemoglobin Manitoba or α2 102(G9)SER→ARGβ2 and Hemoglobin Contaldo or α2 103(G10)HIS→ARGβ2 by high performance liquid chromatography. Hemoglobin. 1984;8(2):169–181.
  • Pullon BM, Moore JA. Hb Manitoba [α102(G9)Ser→Arg] in Pasifika: Tongan Case Report. Hemoglobin. 2020;44(4):290–293.
  • Basset P, Beuzard Y, Garel MC, et al. Isolectric focusing of human hemoglobin: Its application to screening, to the characterization of 70 variants, and to the study of modified fractions of normal hemoglobins. Blood. 1978;51(5):971–982.
  • Khalil MS, Timbs A, Henderson S, et al. Haemoglobin (Hb) G-Philadelphia, Hb Stanleyville-II, Hb G-Norfolk, Hb Matsue-Oki and Hb Mizushi can form a panel of α-chain variants that overlap in their phenotype: the novel use of StyI to screen for Hb G-Philadelphia. Int J Lab Hematol. 2011;33(3):318–325.
  • Khalil MSM, Timbs AT, Henderson SJ, et al. A wide spectrum study of α-globin chain variants: cases from the UK. Hemoglobin. 2020;44(3):195–200.
  • Joutovsky A, Hadzi-Nesic J, Nardi MA. HPLC retention time as a diagnostic tool for hemoglobin variants and hemoglobinopathies: a study of 60000 samples in a clinical diagnostic laboratory. Clin Chem. 2004;50(10):1736–1747.
  • Patrinos GP, Giardine B, Riemer C, et al. Improvements in the HbVar database of human hemoglobin variants and thalassemia mutations for population and sequence variation studies. Nucleic Acids Res. 2004;32(Database issue):D537–D541 (http://globin.cse.psu.edu).
  • Bain BJ. Hemoglobinopathy Diagnosis. 2nd ed. Chichester (West Sussex, UK): Wiley-Blackwell, 2006.
  • Weatherall DJ, Clegg JB, editors. The Thalassaemia Syndromes. 4th ed. Oxford (Oxfordshire, UK): Blackwell Scientific, 2001.
  • Giardine B, Borg J, Viennas E, et al. Updates of the HbVar database of human hemoglobin variants and thalassemia mutations. Nucleic Acids Res. 2014;42(Database issue):D1063–D1069 (http://globin.cse.psu.edu).
  • Labosiere A, Vella F. Hemoglobin I in a white family in Saskatoon. Clin Biochem. 1971;4(1-6):104–113.
  • Vella F. Variation in hemoglobin A2. Hemoglobin. 1977;1(7):619–650.
  • Giordano PC, Maatman RG, Niessen RW. Beta thalassemia IVS-I-5 (G-->C) heterozygosity masked by the presence of HbJ-Meerut in a Dutch-Indian patient. Haematologica. 2006;91(12 Suppl):ECR56.
  • Steinberg MH, Adams JG. 3rd. Hemoglobin A2: origin, evolution, and aftermath. Blood. 1991;78(9):2165–2177.
  • Kutlar F, Gonzalez-Redondo JM, Kutlar A, et al. The levels of zeta, gamma, and delta chains in patients with Hb H disease. Hum Genet. 1989;82(2):179–186.
  • Higgs DR. Alpha-thalassaemia. Bailliére's. Clin Haematol. 1993;6(1):117–150.
  • Khalil MSM, Timbs AT, Henderson SJ, et al. Fifteen cases of Hb J-Meerut: the rare association with Hb E and/or HBA1: c.-24C>G (or HBA2) variants. Hemoglobin. 2020. 2020 Sep 14; doi: 10.1080/03630269.2020.1817755. Online ahead of print.
  • Millimono TS, Loua KM, Rath SL, et al. High prevalence of hemoglobin disorders and glucose-6-phosphatedehydrogenase (G6PD) deficiency in the Republic of Guinea (West Africa). Hemoglobin. 2012;36(1):25–37.
  • Yadav KA, Rusia U. HbQ-India associated with microcytosis: an uncommon hemoglobin variant associated with a common hematologic condition. Turk J Haematol. 2010;27(3):200–203.
  • Verma S, Gupta R, Kudesia M, et al. Coexisting iron deficiency anemia and beta thalassemia trait: effect of iron therapy on red cell parameters and hemoglobin subtypes. ISRN Hematol. 2014;2014:1–5.
  • Sharma M, Pandey S, Ranjan R, et al. Prevalence of alpha thalassemia in microcytic anemia: a tertiary care experience from north India. Mediterr J Hematol Infect Dis. 2015;7(1):e2015004.
  • Chiasakul T, Uaprasert N. Iron deficiency anemia interfering the diagnosis of compound heterozygosity for Hb constant spring and Hb Paksé: the first case report. J Clin Lab Anal. 2018;32(1):e22187.
  • Stephens AD, Angastiniotis M, Baysal E et al., International Council for the Standardisation of Haematology (ICSH) ICSH recommendations for the measurement of haemoglobin A2. Int J Lab Hematol. 2012;34(1):1–13.
  • Kurlekar N, Mehta BC. Haemoglobin A2 levels in iron deficiency anaemia. Indian J Med Res. 1981;73:77–81.
  • Passarello C, Giambona A, Cannata M, et al. Iron deficiency does not compromise the diagnosis of high HbA(2) β thalassemia trait. Haematologica. 2012;97(3):472–473.
  • Hercberg S, Galan P. Nutritional anaemias. Bailliáre's. Clin Haematol. 1992;5(1):143–168.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.